E-LIB Suche - Ergebnisse für: Kappelhoff, Bregt S. - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Cost-effectiveness of tipranavir versus comparator protease..:

Hubben, Gijs AA ; Bos, Jasper M ; Veltman-Starkenburg, Christa A...
Cost Effectiveness and Resource Allocation. 5 (2007) 1 - p. 15 , 2007

Link: https://doi.org/10.1186/..

2

Population pharmacokinetics of indinavir alone and in combi..:

Kappelhoff, Bregt S. ; Huitema, Alwin D. R. ; Sankatsing, Sanjay U. C....
British Journal of Clinical Pharmacology. 60 (2005) 3 - p. 276-286 , 2005

Link: https://doi.org/10.1111/..

3

Practical Guidelines to Interpret Plasma Concentrations of ..:

Kappelhoff, Bregt S ; Huitema, Alwin D R ; Beijnen, Jos H
Clinical Pharmacokinetics. 44 (2005) 4 - p. 439-440 , 2005

Link: https://doi.org/10.2165/..

4

Population Pharmacokinetics of Efavirenz in an Unselected C..:

Kappelhoff, Bregt S ; Huitema, Alwin D R ; Yalva??, Zeynep...
Clinical Pharmacokinetics. 44 (2005) 8 - p. 849-861 , 2005

Link: https://doi.org/10.2165/..

5

Practical Guidelines to Interpret Plasma Concentrations of ..:

Kappelhoff, Bregt S ; Crommentuyn, Kristel M L ; de Maat, Monique M R...
Clinical Pharmacokinetics. 43 (2004) 13 - p. 845-853 , 2004

Link: https://doi.org/10.2165/..

6

Development and validation of a population pharmacokinetic ..:

Kappelhoff, Bregt S. ; Huitema, Alwin D. R. ; Crommentuyn, Kristel M. L....
British Journal of Clinical Pharmacology. 59 (2004) 2 - p. 174-182 , 2004

Link: https://doi.org/10.1111/..

7

Simple and rapid method for the simultaneous determination ..:

Kappelhoff, Bregt S ; Rosing, Hilde ; Huitema, Alwin D.R.
Journal of Chromatography B. 792 (2003) 2 - p. 353-362 , 2003

Link: https://doi.org/10.1016/..

8

Cost-effectiveness of tipranavir versus comparator protease..:

Kappelhoff Bregt S ; Finnern Henrik W ; Stegmeijer Simon...
http://www.resource-allocation.com/content/5/1/15. , 2007

Link: https://doi.org/10.1186/..

9

Cost-effectiveness of tipranavir versus comparator protease..:

Hubben, Gijs A A ; Bos, Jasper M ; Veltman-Starkenburg, Christa A...
https://research.rug.nl/en/publications/cf2b8a7f-e0b3-4c41-98b5-6d07476df1a3. , 2007

Link: https://hdl.handle.net/1..

10

Cost-effectiveness of tipranavir versus comparator protease..:

Hubben, Gijs AA ; Bos, Jasper M ; Veltman-Starkenburg, Christa A...
http://www.resource-allocation.com/content/5/1/15. , 2007

Link: http://www.resource-allo..

11

Population pharmacokinetics of indinavir alone and in combi..:

Kappelhoff, Bregt S ; Huitema, Alwin D R ; Sankatsing, Sanjay U C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884764. , 2005

Link: http://www.ncbi.nlm.nih...

12

Development and validation of a population pharmacokinetic ..:

Kappelhoff, Bregt S ; Huitema, Alwin D R ; Crommentuyn, Kristel M L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884743. , 2005

Link: http://www.ncbi.nlm.nih...

13

The cost-effectiveness and monetary benefits of dabigatran ..:

van Hulst, Marinus ; Stevanovic, Jelena ; Jacobs, Maartje S...
https://research.rug.nl/en/publications/8b5a5c99-0d4c-4952-96c0-fea3564b588e. , 2018

Link: https://hdl.handle.net/1..

14

Dabigatran for the Treatment and Secondary Prevention of Ve..:

Stevanović, J. ; de Jong, L. A. ; Kappelhoff, B. S....
PLOS ONE. 11 (2016) 10 - p. e0163550 , 2016

Link: https://doi.org/10.1371/..

15

Population pharmacokinetics of lopinavir in combination wit..:

Crommentuyn, K. M. L. ; Kappelhoff, B. S. ; Mulder, J. W....
British Journal of Clinical Pharmacology. 60 (2005) 4 - p. 378-389 , 2005

Link: https://doi.org/10.1111/..

1-15